| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/08/2007 | WO2007025760A2 Melanoma-associated mhc class i associated oligopeptides and the uses thereof |
| 03/08/2007 | WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | WO2007025388A2 Anti-apoptotic protein antibodies |
| 03/08/2007 | WO2007025385A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 03/08/2007 | WO2007025343A1 Modified chaperonin 10 |
| 03/08/2007 | WO2006136697A3 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
| 03/08/2007 | WO2006116727A3 Compositions and methods for detection of sirolimus |
| 03/08/2007 | WO2006116076A3 Tab molecules |
| 03/08/2007 | WO2006110760A3 Compositions and methods for the diagnosis and treatment of tumor |
| 03/08/2007 | WO2006105021A3 Gitr binding molecules and uses therefor |
| 03/08/2007 | WO2006103666A3 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 03/08/2007 | WO2006091412A3 Adamts-7 as a biomarker for cancers of epithelial origin |
| 03/08/2007 | WO2006076691A3 Irta-2 antibodies and their uses |
| 03/08/2007 | WO2006074451A3 Targeted chimeric molecules for cancer therapy |
| 03/08/2007 | WO2006020935A3 Stabilizing formulations |
| 03/08/2007 | WO2006014816A3 Canis sphingosine 1-phosphate receptor isoform 2 |
| 03/08/2007 | WO2005123966A3 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 03/08/2007 | WO2005076013B1 Process for screening glycoform-specific antibodies |
| 03/08/2007 | WO2005039393A3 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 03/08/2007 | US20070055056 251 human secreted proteins |
| 03/08/2007 | US20070055054 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070055053 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/08/2007 | US20070055052 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070055050 Methods and reagents for diagnosis and treatment of diabetes |
| 03/08/2007 | US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation |
| 03/08/2007 | US20070054858 Method of treating hepatocellular carcinoma |
| 03/08/2007 | US20070054848 Composition and method for nerve regeneration |
| 03/08/2007 | US20070054390 Method of weak partitioning chromatography |
| 03/08/2007 | US20070054378 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 03/08/2007 | US20070054362 Recombinant production of mixtures of antibodies |
| 03/08/2007 | US20070054361 Compositions and methods for the diagnosis and treatment of tumor |
| 03/08/2007 | US20070054360 Compositions and methods for modulating immune responses |
| 03/08/2007 | US20070054354 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 03/08/2007 | US20070054341 Immunoassay and reagents and kits for performing the same |
| 03/08/2007 | US20070054340 Method and antibodies for detecting nitrofuran |
| 03/08/2007 | US20070054314 Adiponectin receptor and gene encoding the same |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070054303 Expression Vectors and Methods |
| 03/08/2007 | US20070054297 combining drugs with human orphan leucine-repeat-containing, G protein-coupled receptors (LGR7) polypeptides, then evaluating the level of binding to the hromones or the level of cAMP production; drug screening and design |
| 03/08/2007 | US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction |
| 03/08/2007 | US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053938 Virulence of streptococci |
| 03/08/2007 | US20070053928 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| 03/08/2007 | US20070053927 Chlamydia pneumoniae polynucleotides and uses thereof |
| 03/08/2007 | US20070053926 Antigenic neisserial peptides |
| 03/08/2007 | US20070053925 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 03/08/2007 | US20070053917 Composition and method for the treatment and prevention of enteric bacterial infections |
| 03/08/2007 | US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria |
| 03/08/2007 | US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/08/2007 | US20070053914 Antitumor antibodies, proteins, and uses thereof |
| 03/08/2007 | US20070053912 Compounds for neutralizing the effects of secreted pla2iia |
| 03/08/2007 | US20070053909 Method of treating fibrosis |
| 03/08/2007 | US20070053905 treating chondroma and chondrosarcoma by administering humanized anti-PTHrP(1-34) antibody which inhibits binding of parathyroid hormone related peptide to a receptor thereof |
| 03/08/2007 | US20070053904 Antibodies having diagnostic, preventive, therapeutic, and other uses |
| 03/08/2007 | US20070053903 Methods of using pHHLA2 to co-stimulate T-cells |
| 03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
| 03/08/2007 | US20070053901 Optimized Fc variants and methods for their generation |
| 03/08/2007 | US20070053894 Compound and method for regulating plasminogen activation and cell migration |
| 03/08/2007 | US20070053880 Growth differentiation factor-16 |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/08/2007 | US20070053835 Antibodies (monoclonal, humanized) conjugated to antigrowth/cytotoxic agents (maytansinoids, calicheamicins); host cells |
| 03/08/2007 | DE102005041616A1 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and their uses |
| 03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |
| 03/08/2007 | CA2621303A1 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 03/08/2007 | CA2621083A1 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 03/08/2007 | CA2621017A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 03/08/2007 | CA2620802A1 Engineered anti-il-23 antibodies |
| 03/08/2007 | CA2620774A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | CA2620729A1 Modified chaperonin 10 |
| 03/08/2007 | CA2620641A1 Human fvii monoclonal antibodies binding the gla domain and use thereof |
| 03/08/2007 | CA2620515A1 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 03/08/2007 | CA2620470A1 Trail receptor 2 polypeptides and antibodies |
| 03/08/2007 | CA2620351A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 03/08/2007 | CA2619748A1 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 03/08/2007 | CA2616561A1 Therapeutic goose antibodies for treatment and prophylaxis of transmittable viral diseases |
| 03/07/2007 | EP1760155A2 Non-human sperm-DNA complexes for geneticallly modifying non-human animals |
| 03/07/2007 | EP1760087A1 Novel protein complex and use thereof |
| 03/07/2007 | EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 03/07/2007 | EP1759208A1 Identification of antibody-producing cells |
| 03/07/2007 | EP1759013A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 03/07/2007 | EP1758998A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 03/07/2007 | EP1758936A2 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 03/07/2007 | EP1758929A2 Methods for altering protein production rates |
| 03/07/2007 | EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 03/07/2007 | EP1758615A2 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 03/07/2007 | EP1758610A1 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 03/07/2007 | EP1678314A4 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 03/07/2007 | EP1613961A4 Surface receptor complexes as biomarkers |
| 03/07/2007 | EP1551447A4 Anti-addl antibodies and uses thereof |
| 03/07/2007 | EP1547451A4 Cell adhesion resisting surfaces |
| 03/07/2007 | EP1430152B1 Gene and protein relating to hepatocellular carcinoma |
| 03/07/2007 | EP1368379B1 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
| 03/07/2007 | EP1194528B1 Monoclonal antibody for factor VIII, which even when present in molar excess inactivates factor VIII only in part and a method for producing such an antibody |
| 03/07/2007 | EP1044013B1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 03/07/2007 | EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof |
| 03/07/2007 | EP1007638B1 Kcnq potassium channels and methods of modulating same |
| 03/07/2007 | EP0942992B1 O-fucosyltransferase |
| 03/07/2007 | EP0585242B2 Wound healing |